kiss1-protein--human and Mental-Disorders

kiss1-protein--human has been researched along with Mental-Disorders* in 2 studies

Trials

1 trial(s) available for kiss1-protein--human and Mental-Disorders

ArticleYear
Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions.
    JCI insight, 2018, 10-18, Volume: 3, Issue:20

    Resting brain connectivity is a crucial component of human behavior demonstrated by disruptions in psychosexual and emotional disorders. Kisspeptin, a recently identified critical reproductive hormone, can alter activity in certain brain structures but its effects on resting brain connectivity and networks in humans remain elusive.. We determined the effects of kisspeptin on resting brain connectivity (using functional neuroimaging) and behavior (using psychometric analyses) in healthy men, in a randomized double-blinded 2-way placebo-controlled study.. Kisspeptin's modulation of the default mode network (DMN) correlated with increased limbic activity in response to sexual stimuli (globus pallidus r = 0.500, P = 0.005; cingulate r = 0.475, P = 0.009). Furthermore, kisspeptin's DMN modulation was greater in men with less reward drive (r = -0.489, P = 0.008) and predicted reduced sexual aversion (r = -0.499, P = 0.006), providing key functional significance. Kisspeptin also enhanced key mood connections including between the amygdala-cingulate, hippocampus-cingulate, and hippocampus-globus pallidus (all P < 0.05). Consistent with this, kisspeptin's enhancement of hippocampus-globus pallidus connectivity predicted increased responses to negative stimuli in limbic structures (including the thalamus and cingulate [all P < 0.01]).. Taken together, our data demonstrate a previously unknown role for kisspeptin in the modulation of functional brain connectivity and networks, integrating these with reproductive hormones and behaviors. Our findings that kisspeptin modulates resting brain connectivity to enhance sexual and emotional processing and decrease sexual aversion, provide foundation for kisspeptin-based therapies for associated disorders of body and mind.. NIHR, MRC, and Wellcome Trust.

    Topics: Administration, Intravenous; Adult; Brain; Connectome; Cross-Over Studies; Double-Blind Method; Emotions; Female; Healthy Volunteers; Humans; Kisspeptins; Male; Mental Disorders; Nerve Net; Placebos; Psychometrics; Rest; Sexual Behavior; Sexual Dysfunction, Physiological; Young Adult

2018

Other Studies

1 other study(ies) available for kiss1-protein--human and Mental-Disorders

ArticleYear
Dysregulation of kisspeptin and neurogenesis at adolescence link inborn immune deficits to the late onset of abnormal sensorimotor gating in congenital psychological disorders.
    Molecular psychiatry, 2010, Volume: 15, Issue:4

    Neuropsychological syndromes including schizophrenia often do not manifest until late adolescence or early adulthood. Studies attributing a role in brain maintenance to the immune system led us to propose that malfunction of immune-dependent regulation of brain functions at adolescence underlies the late onset of such diseases/syndromes. One such function is sensorimotor gating, the ability to segregate a continuous stream of sensory and cognitive information, and to selectively allocate attention to a significant event by silencing the background (measured by prepulse inhibition; PPI). This activity is impaired in schizophrenia, as well as in several other neuropsychological diseases. Using a model of prenatal immune activation (maternal polyriboinosinic-polyribocytidylic acid (poly I:C) injection), often used as a model for schizophrenia, and in which abnormal PPI has a delayed appearance, we demonstrated a form of immune deficit in the adult offspring. Similar abnormal PPI with a delayed appearance was found in congenitally immune-deficient mice (severe combined immune deficient, SCID), and could be reversed by immune reconstitution. This functional deficit correlated with impairment of both hippocampal neurogenesis and expression of the gene encoding kisspeptin (Kiss1) that manifested at adulthood. Moreover, exogenous administration of a kisspeptin-derived peptide partially reversed the gating deficits in the SCID mice. Our results suggest that a form of congenital immune deficiency may be a key factor that determines manifestation of developmental neuropsychological disorders with onset only at early adulthood.

    Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Hippocampus; Kisspeptins; Lymphocytes; Male; Mental Disorders; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Neural Inhibition; Neurogenesis; Peptides; Poly C; Poly G; Pregnancy; Prenatal Exposure Delayed Effects; Proteins; Psychoacoustics; Rats; Reaction Time; Reflex, Startle; Sensory Gating

2010